A study for evaluating the effect of a food containing lactic acid bacteria on immune modulation functio
- Conditions
- Healthy adult
- Registration Number
- JPRN-UMIN000052242
- Lead Sponsor
- EP Mediate Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 200
Not provided
(1)Subjects who have disease requiring medication, and treatment except dry eye and cavity protection, or have a history of serious treatment (2)Subjects having the disease past medical history that needed a diet and exercise therapy under the management of the doctor (3)Subjects who having atopic dermatitis, bronchial asthma, and chronic bronchitis (4)Subjects who take antiallergic drugs (5)Subjects who cannot restrict the use of medicines or health foods that may influence this study after informed consent (6)Subjects who vaccinated influenza or the corona vaccine within four weeks on preliminary examination and hope for vaccination during an intake period (7)Heavy drinkers of alcohol (8)Heavy excessive smokers (9)Subjects who are planning to travel abroad during the study period, or who are planning of overseas business trip (10)Subjects who are becoming pregnant and lactating or intend to become pregnant (11)Night and day shift worker (12)Subjects who have participated in other clinical studies within one month before giving consent or plan to participate during the present study period (13)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (14)Subjects who are judged as unsuitable for the study based on the results of clinical examination or cardiopulmonary abnormality in the past (15)Subjects having possibilities for emerging allergy relates to the study (16)Subjects who are judges as unsuitable for the study bases on the result of clinical and physical examination on preliminary examination (17)Subjects who are judged as unsuitable for the study by the investigator for other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1)Cumulative score with cold symptoms (2)Cumulative days with cold symptoms
- Secondary Outcome Measures
Name Time Method (1)average score with cold symptoms (2)pDC activity (MFI of CD86, HLA-DR, CD40 and CD80) in the peripheral blood (3)NK activity